Cancer Stem-Like Cells and Cancer Therapeutic Strategy
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Stem Cells".
Deadline for manuscript submissions: closed (23 April 2023) | Viewed by 10160
Special Issue Editor
Interests: multidrug resistance; tyrosine kinase inhibitor; ABC transporters; exosomes; cancer; cancer stem cells
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Cancer stem-like cells are the main causes of carcinogenesis, recurrence, metastasis, and drug resistance. Killing tumor stem cells is expected to cure patients with cancer. Although the concept of tumor stem cells was proposed 40 years ago, the key signaling molecules of cancer stem cell evolution remain unclear. With many scientists working on the key regulatory molecules of the malignant evolution of stem cells and the treatment of targeted cancer stem cells, this Special Issue hopes to publish your achievements in this field while at the same time improving the academic reputation of Cells.
Prof. Dr. Liwu Fu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer
- stemness
- stem cells
- EMT
- dormancy
- targeted therapy
- drug resistance